Back to search
FDAFDA · Food and drugs·Recall number D-0723-2026

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01

Published July 8, 2026 · Recall initiated: June 23, 2026

Summary

FDA records drug Class II recall D-0723-2026, published July 8, 2026 and initiated June 23, 2026. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 64,894 units; Lot: Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if GLUCAGON has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GLUCAGON
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide within the U.S.
UPC
0370748311011
Lot
Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01 recalled?

Yes. FDA published recall D-0723-2026 on July 8, 2026. Reported hazard: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GLUCAGON. UPC: 0370748311011.